Sleep Medicine Reviews
Volume 6, Issue 3 , Pages 175-193 , June 2002

Pulmonary haemodynamics in obstructive sleep apnoea

References 

  1. Lugaresi E, Coccagna G, Mantovani M. Sleep and breathing in normal man. Hypersomnia with periodic apneas. New York: Spectrum Publications; 1978; p. 5–25
  2. *Coccagna G, Mantovani M, Brignani F, Parchi C, Lugaresi E. Continuous recording of the pulmonary and systemic arterial pressure during sleep in syndromes of hypersomnia with periodic breathing. Bull Physio-path Resp. 1972;8:1159–1172
  3. Lonsdorfer J, Meunier-Carus J, Lampert-Benignus E, Kurtz D, Bapst-Reiter J, Fletto R, et al. Aspects hémodynamiques et respiratoires du syndrome Pickwickien. Bull Physio-path Resp. 1972;8:1181–1192
  4. Tilkian AG, Guilleminault C, Schroeder JS, Lehrman KL, Simmons FB, Dement WC. Hemodynamics in sleep-induced apneas. Ann Intern Med. 1976;85:714–719
  5. Buda AJ, Schroeder JS, Guilleminault C. Abnormalities of pulmonary artery wedge pressures in sleep-induced apnea. Int J Cardiol. 1981;1:67–74
  6. Podszus T, Mayer J, Penzel T, Peter JH, von Wichert P. Nocturnal haemodynamics in patients with sleep apnea. Eur J Respir Dis. 1986;69:435–442
  7. *Marrone O, Bellia V, Ferrara G, Milone F, Romano L, Salvaggio A, et al. Transmural pressure measurements. Importance in the assessment of pulmonary hypertension in obstructive sleep apnea. Chest. 1989;95:338–342
  8. *Marrone O, Bonsignore MR, Romano S, Bonsignore G. Slow and fast changes in transmural pulmonary artery pressure in obstructive sleep apnoea. Eur Respir J. 1994;7:2192–2198
  9. Niijima M, Kimura H, Edo H, Shinozaki T, Kang J, Masuyama S, et al. Manifestation of pulmonary hypertension during REM sleep in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1999;159:1766–1772
  10. Sforza E, Laks L, Grunstein RR, Krieger J, Sullivan CE. Time course of pulmonary artery pressure during sleep in sleep apnoea syndrome: role of recurrent apnoeas. Eur Respir J. 1998;11:440–446
  11. Schäfer H, Hasper E, Ewig S, Koehler U, Latzelsberger J, Tasci S, et al. Pulmonary haemodynamics in obstructive sleep apnoea: time course and associated factors. Eur Respir J. 1998;12:679–684
  12. Khatri I, Freis E. Hemodynamic changes during sleep. J Appl Physiol. 1967;22:867–873
  13. Lugaresi E, Cirignotta F, Coccagna G, Montagna P. Clinical significance of snoring. In:  Saunders NA,  Sullivan CE editor. Sleep and breathing. New York-Basel: M.Dekker Inc; 1984;p. 283–298
  14. Tarasiuk A, Scharf SM. Cardiovascular effects of periodic obstructive and central apneas in dogs. Am J Respir Crit Care Med. 1994;150:83–89
  15. Shiomi T, Guilleminault C, Stoohs R, Schnittger I. Leftward shift of the interventricular septum and pulsus paradoxus in obstructive sleep apnea syndrome. Chest. 1991;100:894–902
  16. Garpestad E, Katayama H, Parker JA, Ringler J, Lilly J, Yasuda T, et al. Stroke volume and cardiac output decrease at termination of obstructive apneas. J Appl Physiol. 1992;73:1743–1748
  17. *Schneider H, Schaub CD, Andreoni KA, Schwartz AR, Smith PL, Robotham JL, et al. Systemic and pulmonary hemodynamic responses to normal and obstructed breathing during sleep. J Appl Physiol. 1997;83:1671–1680
  18. Guilleminault C, Motta J, Mihm F, Melvin K. Obstructive apnea and cardiac index. Chest. 1986;89:331–334
  19. Tolle FA, Judy WV, Yu P-L, Markand ON. Reduced stroke volume related to pleural pressure in obstructive sleep apnea. J Appl Physiol. 1983;55:1718–1724
  20. Stoohs R, Guilleminault C. Cardiovascular changes associated with obstructive sleep apnea syndrome. J Appl Physiol. 1992;72:583–589
  21. *Bonsignore MR, Marrone O, Romano S, Pieri D. Time course of right ventricular stroke volume and output in obstructive sleep apneas. Am J Respir Crit Care Med. 1994;149:155–159
  22. Escourrou P, Tessier O, Bureau A, Nedelcoux H, Bourgin P. Non-invasive measurement of haemodynamics during sleep apnoea. J Sleep Res. 1995;4:78–82
  23. Coccagna G, Mantovani M, Brignani F, Parchi C, Lugaresi E. Tracheostomy in hypersomnia with periodic breathing. Bull Physio-path Resp. 1972;8:1217–1227
  24. Motta J, Guilleminault C, Schroeder JS, Dement WC. Tracheostomy and hemodynamic changes in sleep-induced apnea. Ann Intern Med. 1978;89:454–458
  25. Marrone O, Milone F, Ferrara G, Romano L, Bellia V. Transmural pulmonary artery pressure during CPAP in obstructive sleep apnoea syndrome. Eur Respir J. 1990;3:S544–545
  26. Palasiewicz G, Sliwinski P, Koziej M, Zielinski J. Acute effects of CPAP and BiPAP breathing on pulmonary hemodynamics in patients with obstructive sleep apnoea. Monaldi Arch Chest Dis. 1997;52:440–443
  27. Akashiba T, Minemura H, Yamamoto H, Itoh D, Kosaka N, Saitoh O, et al. Effect of continuous positive airway pressure on pulmonary haemodynamics and tissue oxygenation in patients with obstructive sleep apnoea. Respirology. 1999;4:83–87
  28. Becker H, Grote L, Ploch T, Schneider H, Stammnitz A, Peter JH, et al. Intrathoracic pressure changes and cardiovascular effects induced by nCPAP and nBiPAP in sleep apnoea patients. J Sleep Res. 1995;4:125–129
  29. Leech JA, Ascah KJ. Hemodynamic effects of nasal CPAP examined by doppler echocardiography. Chest. 1991;99:323–326
  30. Schroeder JS, Motta J, Guilleminault C. Hemodynamic studies in sleep apnea. In:  Guilleminault C,  Dement WC editor. Sleep-apnea syndromes. New York: Alan R. Liss; 1978;p. 177–196
  31. Marrone O, Bellia V, Pieri D, Salvaggio A, Bonsignore G. Acute effects of oxygen administration on transmural pulmonary artery pressure in obstructive sleep apnea. Chest. 1992;101:1023–1027
  32. Iwase N, Kikuchi Y, Hida W, Miki H, Taguchi O, Satoh M, et al. Effects of repetitive airway obstruction on O2 saturation and systemic and pulmonary arterial pressure in anesthetized dogs. Am Rev Respir Dis. 1992;146:1402–1410
  33. Schneider H, Schaub CD, Chen CA, Andreoni KA, Schwartz AR, Smith PL, et al. Neural and local effects of hypoxia on cardiovascular responses to obstructive apnea. J Appl Physiol. 2000;88:1093–2000
  34. Cutaia M, Rounds S. Hypoxic pulmonary vasoconstriction. Physiologic significance, mechanisms,ans clinical relevance. Chest. 1990;97:706–718
  35. Dorrington KL, Clar C, Young JD, Jonas M, Tansley JG, Robbins PA. Time course of the human pulmonary vascular response to 8 hours of isocapnic hypoxia. Am J Physiol. 1997;273:H1126–H1134
  36. Laks L, Lehraft B, Grunstein RR, Sullivan CE. Pulmonary artery pressure response to hypoxia in sleep apnea. Am J Respir Crit Care Med. 1997;155:193–198
  37. Marshall BE, Marshall C. Acidosis and the pulmonary circulation. In:  Arieff AI editors. Hypoxia, metabolic acidosis and the circulation. New York: American Physiological Society, Oxford University Press; 1992;p. 99–115
  38. Schneider H, Schaub CD, Chen CA, Andreoni KA, Schwartz AR, Smith PL, et al. Effects of arousal and sleep state on systemic and pulmonary hemodynamics in obstructive apnea. J Appl Physiol. 2000;88:1088–1092
  39. Ali N, Davies R, Fleetham J, Stradling J. Periodic movements of legs during sleep associated with rises in systemic blood pressure. Sleep. 1991;14:163–165
  40. Salvi SS. α1-adrenergic hypothesis for pulmonary hypertension. Chest. 1999;115:1708–1719
  41. Scharf SM. Cardiovascular effects of airways obstruction. Lung. 1991;169:1–23
  42. Chaudary BA, Ferguson DS, Speir WA. Pulmonary edema as a presenting feature of sleep apnea syndrome. Chest. 1982;82:122–124
  43. Fletcher EC, Proctor M, Yu J, Zhang J, Guardiola JJ, Hornung C, et al. Pulmonary edema develops after recurrent obstructive apneas. Am J Respir Crit Care Med. 1999;160:1688–1696
  44. Garpestad E, Parker JA, Katayama H, Lilly J, Yasuda T, Ringler J, et al. Decrease in ventricular stroke volume at apnea termination is independent of oxygen desaturation. J Appl Physiol. 1994;77:1602–1608
  45. Schäfer H, Ehlenz K, Ewig S, Hasper E, Koehler U, Latzelsberger J, et al. Atrial natriuretic peptide levels and pulmonary artery pressure awake, at exercise and asleep in obstructive sleep apnoea syndrome. J Sleep Res. 1999;8:205–210
  46. Podszus T, Bauer W, Mayer J, Penzel T, Peter JH, von Wichert P. Sleep apnea and pulmonary hypertension. Klin Wochenschr. 1986;64:131–134
  47. Weitzenblum E, Krieger J, Apprill M, Vallée E, Ehrhart M, Ratomaharo J, et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis. 1988;138:345–349
  48. Krieger J, Sforza E, Apprill M, Lampert E, Weitzenblum E, Ratomaharo J. Pulmonary hypertension, hypoxemia and hypercapnia in obstructive sleep apnea patients. Chest. 1989;96:729–737
  49. *Chaouat A, Weitzenblum E, Krieger J, Oswald M, Kessler R. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Chest. 1996;109:380–386
  50. Sajkov D, Cowie RJ, Thornton AT, Espinoza HA, McEvoy RD. Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1994;149:416–422
  51. Laks L, Lehrharft B, Grunstein RR, Sullivan CE. Pulmonary hypertension in obstructive sleep apnea. Eur Respir J. 1995;8:537–541
  52. Sanner BM, Doberauer C, Konermann M, Sturm A, Zidek W. Pulmonary hypertension in patients with obstructive sleep apnea syndrome. Arch Intern Med. 1997;157:2483–2487
  53. Laaban J-P, Cassuto D, Orvoèn-Frija E, Iliou M-C, Mundler O, Léger D, et al. Cardiorespiratory consequences of sleep apnoea syndrome in patients with massive obesity. Eur Respir J. 1998;11:20–27
  54. *Sajkov D, Wang T, Saunders NA, Bune AJ, Neill AM, McEvoy RD. Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. Am J Respir Crit Care Med. 1999;159:1518–1526
  55. Bady E, Achkar A, Pascal S, Orvoen-Frija E, Laaban J-P. Pulmonary arterial hypertension in patients with sleep apnea syndrome. Thorax. 2000;55:934–939
  56. *Fletcher EC, Schaaf JW, Miller J, Fletcher JC. Long-term cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease. Am Rev Respir Dis. 1987;135:525–533
  57. Kita H, Ohi M, Chin K, Noguchi T, Otsuka N, Tsuboi T, et al. The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure. J Sleep Res. 1998;7:199–207
  58. Schultz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lücke C, Mayer K, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax. 2000;55:1046–1051
  59. Grimpen F, Kanne P, Schultz E, Hagenah G, Hasenfuss G, Andreas S. Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea. Eur Respir J. 2000;15:320–325
  60. Chaouat A, Weitzenblum E, Krieger J, Sforza E, Hammad H, Oswald M, et al. Prognostic value of lung function and pulmonary haemodynamics in OSA patients treated with CPAP. Eur Respir J. 1998;13:1091–1096
  61. Ahmed Q, Chung-Park M, Tomashefski JF. Cardiopulmonary pathology in patients with sleep apnea/obesity hypoventilation syndrome. Human Pathol. 1997;28:264–269
  62. Hedner J, Ejnell H, Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens. 1990;8:941–946
  63. Berman EJ, DiBenedetto RJ, Causey DE, Mims T, Conneff M, Goodman LS, et al. Right ventricular hypertrophy detected by echocardiography in patients with newly diagnosed obstructive sleep apnea. Chest. 1991;100:347–350
  64. Hanly P, Sasson Z, Zuberi N, Alderson M. Ventricular function in snorers and patients with obstructive sleep apnea. Chest. 1992;102:100–105
  65. Davidson WR. Ventricular hypertrophy in sleep apnoea. J Sleep Res. 1995;4:176–181
  66. Noda A, Okada T, Yasuma F, Nakashima N, Yokota M. Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest. 1995;107:1538–1544
  67. Salejee I, Tarasiuk A, Reder I, Scharf SM. Chronic upper airway obstruction produces right but not left ventricular hypertrophy in rats. Am Rev Respir Dis. 1993;148:1346–1350
  68. Bradley TD, Rutherford A, Grossman RF, Lue F, Zamel N, Moldofsky H, et al. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis. 1985;131:835–839
  69. Nahmias J, Lao R, Karetzky M. Right ventricular dysfunction in obstructive sleep apnoea: reversal with nasal continuous positive airway pressure. Eur Respir J. 1996;9:945–951
  70. Sanner BM, Konermann M, Sturm A, Müller HJ, Zidek W. Right ventricular dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J. 1997;10:2079–2083
  71. Sforza E, Krieger J, Weitzenblum E, Apprill M, Lampert E, Ratomaharo J. Long-term effects of treatment with nasal continuous positive airway pressure on daytime lung function and pulmonary hemodynamics in patients with obstructive sleep apnea. Am Rev Respir Dis. 1990;141:866–870
  72. *Chaouat A, Weitzenblum E, Kessler R, Oswald M, Sforza E, Liegeon M-N, et al. Five-year effect of nasal continuous positive airway pressure in obstructive sleep apnoea syndrome. Eur Respir J. 1997;10:2578–2582
  73. Tal A, Leiberman A, Margulis G, Sofer S. Ventricular dysfunction in children with obstructive sleep apnea: Radionuclide assessment. Pediatr Pulmonol. 1988;4:139–143

PII: S1087-0792(01)90185-6

doi: 10.1053/smrv.2001.0185

Sleep Medicine Reviews
Volume 6, Issue 3 , Pages 175-193 , June 2002

Article Tools